Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Deferred Taxes: 2024-2025

Historic Deferred Taxes for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to $1,000.

  • Silence Therapeutics' Deferred Taxes fell 97.96% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $11,000, marking a year-over-year decrease of 98.56%. This contributed to the annual value of $845,000 for FY2024, which is 11.61% down from last year.
  • As of Q3 2025, Silence Therapeutics' Deferred Taxes stood at $1,000, which was down 90.00% from $10,000 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Deferred Taxes ranged from a high of $324,000 in Q4 2024 and a low of $1,000 during Q3 2025.